Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of WisdomTree BioRevolution Fund (BATS:WDNA) through any online brokerage.
There are no as such competitors for WisdomTree BioRevolution Fund.
There is no analysis for WisdomTree BioRevolution Fund to provide a consensus price target.
The stock price for WisdomTree BioRevolution Fund (BATS: WDNA) is $23.1851 last updated August 28, 2026 at 8:00 PM EDT.
There are no upcoming dividends for WisdomTree BioRevolution Fund.
WisdomTree BioRevolution Fund does not have any upcoming earnings scheduled.
There is no upcoming split for WisdomTree BioRevolution Fund.
| Sector | Other |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Jun 3, 2021 |
| Managers | Michael Stoll David France Marlene Walker Smith Todd Frysinger Vlasta Sheremeta |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| LLY | Eli Lilly & Company | 4.10% |
| MRNA | Mrna Uw Equity | 3.48% |
| JNJ | Johnson & Johnson Com | 3.00% |
| UTHR | United Therapeutics Co... | 2.36% |
| TWST | Twist Bioscience Corpo... | 7.08% |
| IMNM | Immunome Inc | 2.68% |
| DAR | Darling Ingredients In... | 2.18% |
| TEM | Tempus Ai, Inc. | 2.12% |
| TXG | 10X Genomics Inc Class... | 2.71% |
| NTRA | Natera | 2.67% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.